Fifth Third Bancorp
ENTA icon

Fifth Third Bancorp’s Enanta Pharmaceuticals ENTA Stock Holding History

Fifth Third Bancorp’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.35K Hold
367
– – ﹤0.01% 3906
2026
Q1 		$4.63K Buy
+367
New +$4.92K ﹤0.01% 3886
2025
Q3 		– Sell
-111
Closed -$839 – 2696
2025
Q2 		$839 Buy
+111
New +$668 ﹤0.01% 2447
2023
Q4 		– Sell
-358
Closed -$4K – 2537
2023
Q3 		$4K Buy
358
+339
+1,784% +$5.46K ﹤0.01% 2231
2023
Q2 		$407 Sell
19
-25
-57% -$737 ﹤0.01% 2565
2023
Q1 		$1.78K Hold
44
– – ﹤0.01% 2567
2022
Q4 		$2.05K Hold
44
– – ﹤0.01% 2427
2022
Q3 		$2K Hold
44
– – ﹤0.01% 2420
2022
Q2 		$2K Sell
44
-18
-29% -$977 ﹤0.01% 2428
2022
Q1 		$4K Sell
62
-2
-3% -$130 ﹤0.01% 2359
2021
Q4 		$5K Buy
64
+45
+237% +$3.53K ﹤0.01% 2321
2021
Q3 		$1K Buy
+19
New +$939 ﹤0.01% 2560
2019
Q4 		– Sell
-28
Closed -$2K – 2237
2019
Q3 		$2K Buy
+28
New +$2.08K ﹤0.01% 2047
2016
Q1 		– Sell
-37
Closed -$1K – 2408
2015
Q4 		$1K Sell
37
-21
-36% -$684 ﹤0.01% 2594
2015
Q3 		$2K Buy
+58
New +$2.49K ﹤0.01% 2592

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fifth Third Bancorp's ENTA Position: Q2 2026 in Review

Fifth Third Bancorp held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 367 shares worth $5.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3906.

Fifth Third Bancorp first reported a position in ENTA in Q3 2015 and has held it in 15 quarters since. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Fifth Third Bancorp held 367 shares of Enanta Pharmaceuticals worth $5.35K as of Q2 2026.
  • Fifth Third Bancorp left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3906 holding.
  • Fifth Third Bancorp first reported a position in Enanta Pharmaceuticals in Q3 2015 and has held it in 15 quarters since.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.